(Q37403648)

20 August 2017

1 reference

title

Phase 3 trials of aromatase inhibitors for breast cancer prevention: following in the path of the selective estrogen receptor modulators (English)

1 reference

20 August 2017

main subject

phase III clinical trial

0 references

1 reference

Barbara K Dunn

1

1 reference

20 August 2017

Anne Ryan

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 February 2009

1 reference

Annals of the New York Academy of Sciences

20 August 2017

published in

1 reference

20 August 2017

volume

1155

1 reference

20 August 2017

page(s)

141-161

1 reference

Incidence of bilateral tumours in a population-based series of breast-cancer patients. I. Two approaches to an epidemiological analysis

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2009.03688.X

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2009.03688.X

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2009.03688.X

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety upda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2009.03688.X

10.1111/J.1749-6632.2009.03688.X

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference